The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy

Autor: L Bartalena, G J Kahaly, L Baldeschi, C M Dayan, A Eckstein, C Marcocci, M Marinò, B Vaidya, W M Wiersinga, Goksun Ayvaz, Onur Konuk, Jasmina Ciric, Bijliana Beleslin, Antonella Boschi, Maria Cristina Burlacu, Dan Morris, Rosario Le Moli, Antonio Marino, Justin McKee, Nicola Zammit, Dagmar Führer, Ioana Pereni, Michael Schittkowski, Dirk Raddatz, Vickie Lee, Karim Meeran, Juliette Abeillon, Thia Soui Thcong, Katharina Ponto, Ilaria Muller, Nicola Currò, Christoph Hintschich, Roland Gärtner, Simon Pearce, Lucy Clarke, Thomas Brix, Dorte Bechtold, Gottfried Rudovfsky, Nicole Fichter, Laurence Du Pasquier, Julia Meney, Francesca Menconi, Giulia Lanzolla, Gangadhara Sundar, Samantha Peiling Yung, Kostas Boboridis, Panagiotis Anagnostis, Marta Pérez Lopez, Carlos Javier Sanchez, Maria Laura Tanda, Simone Donati, Andrea Papp, Shuren Li, Anna Jablonska, Piotr Miskiewicz, Jelena Juri Mandic, Maja Baretic

Publikováno v: European journal of endocrinology, Vol. 185, no. 4, p. G43-G67 (2021)
European Journal of Endocrinology, 185(4), G43-G67. BioScientifica Ltd.

Graves’ orbitopathy (GO) is the main extrathyroidal manifestation of Graves’ disease (GD). Choice of treatment should be based on the assessment of clinical activity and severity of GO. Early referral to specialized centers is fundamental for mos

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71629229c4ad08577973ef207b8d40a5
https://doi.org/10.1530/eje-21-0479

A multidimensional cohort study of late toxicity after intensity modulated radiotherapy for sinonasal cancer

Autor: Ali Amidi, Simon Fristed Eskildsen, Dorte Bechtold, Jens Otto Lunde Jørgensen, Cai Grau, Mikkel Funding, M.B. Sharma, Kenneth Jensen, Steen F Urbak, Jørgen Johansen

Publikováno v: Sharma, M B, Jensen, K, Urbak, S F, Funding, M, Johansen, J, Bechtold, D, Amidi, A, Eskildsen, S F, Jørgensen, J O L & Grau, C 2020, ' A multidimensional cohort study of late toxicity after intensity modulated radiotherapy for sinonasal cancer ', Radiotherapy & Oncology, vol. 151, pp. 58-65 . https://doi.org/10.1016/j.radonc.2020.07.029
Sharma, M B, Jensen, K, Urbak, S F, Funding, M, Johansen, J, Bechtold, D, Amidi, A, Eskildsen, S F, Jørgensen, J O L & Grau, C 2020, ' A multidimensional cohort study of late toxicity after intensity modulated radiotherapy for sinonasal cancer ', Radiotherapy and Oncology, vol. 151, pp. 58-65 . https://doi.org/10.1016/j.radonc.2020.07.029

PURPOSE: To evaluate the occurrence of late toxicity after curatively intended intensity modulated radiotherapy (IMRT) for sinonasal cancer and assess dose-response associations.METHODS: Patients treated with IMRT in 2008-2016 were included. Cross se

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e922fef6d67bf3c9628911737a83fd0e
https://pure.au.dk/portal/da/publications/a-multidimensional-cohort-study-of-late-toxicity-after-intensity-modulated-radiotherapy-for-sinonasal-cancer(c69a5cd7-7ac0-4d3a-b7ce-897dbc8c0097).html

Plexiform Neurofibroma of the Eye Region Occurring in Patients Without Neurofibromatosis Type 1

Autor: Hanne D. Hove, Jan Ulrik Prause, Peter B. Toft, Steffen Heegaard, Dorte Bechtold

Publikováno v: Ophthalmic Plastic & Reconstructive Surgery. 28:413-415

Purpose The purpose of the present study was to investigate the correlation between Plexiform Neurofibroma (PN) of the eye region and Neurofibromatosis type 1 (NF1). According to the textbooks of ophthalmology, PN and NF1 are very closely linked. Our

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe7bc82a75386acc317856361b35d4c8
https://doi.org/10.1097/iop.0b013e3182627ea1